aid: empirico
name: Empirico
description: Empirico is a biotechnology company that powers therapeutic discovery with
  human genetics and small interfering RNA (siRNA) medicines. Combining internal capabilities
  in human genetics and siRNA chemistry with partner expertise, the company identifies
  naturally occurring genetic variations associated with health benefits and develops
  precision oligonucleotide therapeutics for common diseases with significant unmet
  medical need. In October 2024 Empirico entered a licensing agreement with GSK worth
  up to $745 million for a clinical-stage oligonucleotide targeting respiratory disease
  (COPD). Empirico is backed by DCVC. It is a pharmaceutical R&D company and does not
  operate a public technology or API platform.
url: https://raw.githubusercontent.com/api-evangelist/empirico/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.empiri.co/wp-content/uploads/2023/11/logo-empirico.svg
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Human Genetics
- siRNA
- Therapeutics
- Life Sciences
apis: []
common:
- type: Website
  url: https://www.empiri.co/
- type: About
  url: https://www.empiri.co/our-company/
- type: News
  url: https://www.empiri.co/investors-news/
- type: Careers
  url: https://www.empiri.co/careers/
- type: PrivacyPolicy
  url: https://www.empiri.co/privacy-policy/
- type: TermsOfService
  url: https://www.empiri.co/terms-of-use/
- type: LinkedIn
  url: https://www.linkedin.com/company/empiricoinc/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence